Z. Chati , S. Tissier , C. Balaj , M. Lafitte , N. Benzaghou , M. Amor , J. Emoine , M. Angioi , C.-H. Maigrat , G. Farah , K. Belhadj , J. Schwartz , A. Olivier , C. Breton , J.-P. Simon
{"title":"心肌缺血解剖和功能筛查后心肌血运重建的两年随访：来自“南希缺血登记”的见解","authors":"Z. Chati , S. Tissier , C. Balaj , M. Lafitte , N. Benzaghou , M. Amor , J. Emoine , M. Angioi , C.-H. Maigrat , G. Farah , K. Belhadj , J. Schwartz , A. Olivier , C. Breton , J.-P. Simon","doi":"10.1016/j.acvd.2024.10.063","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Myocardial revascularization after screening for myocardial ischemia is one of the main Major Adverse Cardiovascular Events (MACE) observed. Careful monitoring of patients could play an important role.</div></div><div><h3>Objective</h3><div>Systematic monitoring of patients after a myocardial revascularization procedure is known from randomized clinical trials. A real follow-up outside of this context is not really known. In a real world, Nancy Ischemia Registry aims to prospectively study the consequences of screening for myocardial ischemia on subsequent myocardial revascularization.</div></div><div><h3>Method</h3><div>After prospectively including 2977 patients as part of screening for myocardial ischemia by anatomical (Coronary Calcium-Scores, CT-Coronary Angiograms) and functional imaging (Stress Echo, Stress CMR) between May 2021 and the end of December 2022, we observed the occurrence of a myocardial revascularization procedure in these patients. After a positive screening for myocardial ischemia, a coronary angiography was performed. A first myocardial revascularization procedure was decided if the patient presented at least one significant coronary lesion (≥<!--> <!-->70% or FFR<!--> <!-->≤<!--> <!-->0.80).</div></div><div><h3>Results</h3><div>In 2,375 patients, screening did not reveal significant myocardial ischemia (ISCHEMIA<!--> <!-->−). We noted 602 examinations (20% of all examinations) with suspicion of myocardial ischemia (ISCHEMIA<!--> <!-->+). 324 patients (11% of all examinations) (REAVASC<!--> <!-->+) benefited from a first myocardial revascularization in the following weeks. All patients in the three groups had usual follow-up. At the end of 2023, in the ISCHEMIA<!--> <!-->−<!--> <!-->group, we had recorded two cases of myocardial revascularization. In the ISCHEMIA<!--> <!-->+<!--> <!-->group, 97 new revascularization interventions were recorded. However, at least one other myocardial revascularization procedure was observed in 73 patients in the REVASC<!--> <!-->+<!--> <!-->group.</div></div><div><h3>Conclusion</h3><div>Far from the context of randomized clinical trials, non-systematic, but regular, monitoring of patients with suspected myocardial ischemia and/or revascularization shows the interest of anatomical and functional imaging to probably avoid a more significant evolution of MACE and allows for better stratification of patients.</div></div>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":"118 1","pages":"Page S9"},"PeriodicalIF":2.9000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Two-year follow-up of myocardial revascularization after anatomical and functional screening for myocardial ischemia: Insights from the “Nancy Ischemia Registry”\",\"authors\":\"Z. Chati , S. Tissier , C. Balaj , M. Lafitte , N. Benzaghou , M. Amor , J. Emoine , M. Angioi , C.-H. Maigrat , G. Farah , K. Belhadj , J. Schwartz , A. Olivier , C. Breton , J.-P. Simon\",\"doi\":\"10.1016/j.acvd.2024.10.063\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Myocardial revascularization after screening for myocardial ischemia is one of the main Major Adverse Cardiovascular Events (MACE) observed. Careful monitoring of patients could play an important role.</div></div><div><h3>Objective</h3><div>Systematic monitoring of patients after a myocardial revascularization procedure is known from randomized clinical trials. A real follow-up outside of this context is not really known. In a real world, Nancy Ischemia Registry aims to prospectively study the consequences of screening for myocardial ischemia on subsequent myocardial revascularization.</div></div><div><h3>Method</h3><div>After prospectively including 2977 patients as part of screening for myocardial ischemia by anatomical (Coronary Calcium-Scores, CT-Coronary Angiograms) and functional imaging (Stress Echo, Stress CMR) between May 2021 and the end of December 2022, we observed the occurrence of a myocardial revascularization procedure in these patients. After a positive screening for myocardial ischemia, a coronary angiography was performed. A first myocardial revascularization procedure was decided if the patient presented at least one significant coronary lesion (≥<!--> <!-->70% or FFR<!--> <!-->≤<!--> <!-->0.80).</div></div><div><h3>Results</h3><div>In 2,375 patients, screening did not reveal significant myocardial ischemia (ISCHEMIA<!--> <!-->−). We noted 602 examinations (20% of all examinations) with suspicion of myocardial ischemia (ISCHEMIA<!--> <!-->+). 324 patients (11% of all examinations) (REAVASC<!--> <!-->+) benefited from a first myocardial revascularization in the following weeks. All patients in the three groups had usual follow-up. At the end of 2023, in the ISCHEMIA<!--> <!-->−<!--> <!-->group, we had recorded two cases of myocardial revascularization. In the ISCHEMIA<!--> <!-->+<!--> <!-->group, 97 new revascularization interventions were recorded. However, at least one other myocardial revascularization procedure was observed in 73 patients in the REVASC<!--> <!-->+<!--> <!-->group.</div></div><div><h3>Conclusion</h3><div>Far from the context of randomized clinical trials, non-systematic, but regular, monitoring of patients with suspected myocardial ischemia and/or revascularization shows the interest of anatomical and functional imaging to probably avoid a more significant evolution of MACE and allows for better stratification of patients.</div></div>\",\"PeriodicalId\":55472,\"journal\":{\"name\":\"Archives of Cardiovascular Diseases\",\"volume\":\"118 1\",\"pages\":\"Page S9\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Cardiovascular Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S187521362400408X\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/15 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Cardiovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S187521362400408X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/15 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Two-year follow-up of myocardial revascularization after anatomical and functional screening for myocardial ischemia: Insights from the “Nancy Ischemia Registry”
Introduction
Myocardial revascularization after screening for myocardial ischemia is one of the main Major Adverse Cardiovascular Events (MACE) observed. Careful monitoring of patients could play an important role.
Objective
Systematic monitoring of patients after a myocardial revascularization procedure is known from randomized clinical trials. A real follow-up outside of this context is not really known. In a real world, Nancy Ischemia Registry aims to prospectively study the consequences of screening for myocardial ischemia on subsequent myocardial revascularization.
Method
After prospectively including 2977 patients as part of screening for myocardial ischemia by anatomical (Coronary Calcium-Scores, CT-Coronary Angiograms) and functional imaging (Stress Echo, Stress CMR) between May 2021 and the end of December 2022, we observed the occurrence of a myocardial revascularization procedure in these patients. After a positive screening for myocardial ischemia, a coronary angiography was performed. A first myocardial revascularization procedure was decided if the patient presented at least one significant coronary lesion (≥ 70% or FFR ≤ 0.80).
Results
In 2,375 patients, screening did not reveal significant myocardial ischemia (ISCHEMIA −). We noted 602 examinations (20% of all examinations) with suspicion of myocardial ischemia (ISCHEMIA +). 324 patients (11% of all examinations) (REAVASC +) benefited from a first myocardial revascularization in the following weeks. All patients in the three groups had usual follow-up. At the end of 2023, in the ISCHEMIA − group, we had recorded two cases of myocardial revascularization. In the ISCHEMIA + group, 97 new revascularization interventions were recorded. However, at least one other myocardial revascularization procedure was observed in 73 patients in the REVASC + group.
Conclusion
Far from the context of randomized clinical trials, non-systematic, but regular, monitoring of patients with suspected myocardial ischemia and/or revascularization shows the interest of anatomical and functional imaging to probably avoid a more significant evolution of MACE and allows for better stratification of patients.
期刊介绍：
The Journal publishes original peer-reviewed clinical and research articles, epidemiological studies, new methodological clinical approaches, review articles and editorials. Topics covered include coronary artery and valve diseases, interventional and pediatric cardiology, cardiovascular surgery, cardiomyopathy and heart failure, arrhythmias and stimulation, cardiovascular imaging, vascular medicine and hypertension, epidemiology and risk factors, and large multicenter studies. Archives of Cardiovascular Diseases also publishes abstracts of papers presented at the annual sessions of the Journées Européennes de la Société Française de Cardiologie and the guidelines edited by the French Society of Cardiology.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
